Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality

Abstract Background The long‐term relationship between fracture‐prone implantable cardioverter‐defibrillator (ICD) leads and poor prognosis remains unclear in Japanese patients. Methods We conducted a retrospective review of the records of 445 patients who underwent implantation of advisory/Linox le...

Full description

Bibliographic Details
Main Authors: Toshiharu Koike, Morio Shoda, Koichiro Ejima, Daigo Yagishita, Atsushi Suzuki, Shun Hasegawa, Shohei Kataoka, Kyoichiro Yazaki, Satoshi Higuchi, Miwa Kanai, Junichi Yamaguchi
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Journal of Arrhythmia
Subjects:
Online Access:https://doi.org/10.1002/joa3.12843
_version_ 1797804554725621760
author Toshiharu Koike
Morio Shoda
Koichiro Ejima
Daigo Yagishita
Atsushi Suzuki
Shun Hasegawa
Shohei Kataoka
Kyoichiro Yazaki
Satoshi Higuchi
Miwa Kanai
Junichi Yamaguchi
author_facet Toshiharu Koike
Morio Shoda
Koichiro Ejima
Daigo Yagishita
Atsushi Suzuki
Shun Hasegawa
Shohei Kataoka
Kyoichiro Yazaki
Satoshi Higuchi
Miwa Kanai
Junichi Yamaguchi
author_sort Toshiharu Koike
collection DOAJ
description Abstract Background The long‐term relationship between fracture‐prone implantable cardioverter‐defibrillator (ICD) leads and poor prognosis remains unclear in Japanese patients. Methods We conducted a retrospective review of the records of 445 patients who underwent implantation of advisory/Linox leads (Sprint Fidelis, 118; Riata, nine; Isoline, 10; Linox S/SD, 45) and non‐advisory leads (Endotak Reliance, 33; Durata, 199; Sprint non‐Fidelis, 31) between January 2005 and June 2012 at our hospital. The primary outcomes were all‐cause mortality and ICD lead failure. The secondary outcomes were cardiovascular mortality, heart failure (HF) hospitalization, and the composite outcome of cardiovascular mortality and HF hospitalization. Results During the follow‐up period (median, 8.6 [4.1–12.0] years), there were 152 deaths: 61 (34%) in patients with advisory/Linox leads and 91 (35%) in those with non‐advisory leads. There were 32 ICD lead failures: 27 (15%) in patients with advisory/Linox leads and five (2%) in those with non‐advisory leads. Multivariate analysis for ICD lead failure demonstrated that the advisory/Linox leads had a 6.65‐fold significantly greater risk of ICD lead failure than non‐advisory leads. Congenital heart disease (hazard ratio 2.51; 95% confidence interval 1.08–5.83; p = .03) could also independently predict ICD lead failure. Multivariate analysis for all‐cause mortality demonstrated no significant association between advisory/Linox leads and all‐cause mortality. Conclusions Patients who have implanted fracture‐prone ICD leads should be carefully followed up for ICD lead failure. However, these patients have a long‐term survival rate comparable with that of patients with non‐advisory ICD leads in Japanese patients.
first_indexed 2024-03-13T05:37:54Z
format Article
id doaj.art-c5d9cae62e0445cdadb7a727377bed50
institution Directory Open Access Journal
issn 1880-4276
1883-2148
language English
last_indexed 2024-03-13T05:37:54Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Journal of Arrhythmia
spelling doaj.art-c5d9cae62e0445cdadb7a727377bed502023-06-14T05:25:21ZengWileyJournal of Arrhythmia1880-42761883-21482023-06-0139345446310.1002/joa3.12843Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortalityToshiharu Koike0Morio Shoda1Koichiro Ejima2Daigo Yagishita3Atsushi Suzuki4Shun Hasegawa5Shohei Kataoka6Kyoichiro Yazaki7Satoshi Higuchi8Miwa Kanai9Junichi Yamaguchi10Department of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanDepartment of Cardiology Tokyo Women's Medical University 8‐1 Kawada‐cho, Shinjuku‐ku Tokyo 162‐8666 JapanAbstract Background The long‐term relationship between fracture‐prone implantable cardioverter‐defibrillator (ICD) leads and poor prognosis remains unclear in Japanese patients. Methods We conducted a retrospective review of the records of 445 patients who underwent implantation of advisory/Linox leads (Sprint Fidelis, 118; Riata, nine; Isoline, 10; Linox S/SD, 45) and non‐advisory leads (Endotak Reliance, 33; Durata, 199; Sprint non‐Fidelis, 31) between January 2005 and June 2012 at our hospital. The primary outcomes were all‐cause mortality and ICD lead failure. The secondary outcomes were cardiovascular mortality, heart failure (HF) hospitalization, and the composite outcome of cardiovascular mortality and HF hospitalization. Results During the follow‐up period (median, 8.6 [4.1–12.0] years), there were 152 deaths: 61 (34%) in patients with advisory/Linox leads and 91 (35%) in those with non‐advisory leads. There were 32 ICD lead failures: 27 (15%) in patients with advisory/Linox leads and five (2%) in those with non‐advisory leads. Multivariate analysis for ICD lead failure demonstrated that the advisory/Linox leads had a 6.65‐fold significantly greater risk of ICD lead failure than non‐advisory leads. Congenital heart disease (hazard ratio 2.51; 95% confidence interval 1.08–5.83; p = .03) could also independently predict ICD lead failure. Multivariate analysis for all‐cause mortality demonstrated no significant association between advisory/Linox leads and all‐cause mortality. Conclusions Patients who have implanted fracture‐prone ICD leads should be carefully followed up for ICD lead failure. However, these patients have a long‐term survival rate comparable with that of patients with non‐advisory ICD leads in Japanese patients.https://doi.org/10.1002/joa3.12843advisory leadimplantable cardioverter‐defibrillator leadlead failureLinoxmortality
spellingShingle Toshiharu Koike
Morio Shoda
Koichiro Ejima
Daigo Yagishita
Atsushi Suzuki
Shun Hasegawa
Shohei Kataoka
Kyoichiro Yazaki
Satoshi Higuchi
Miwa Kanai
Junichi Yamaguchi
Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
Journal of Arrhythmia
advisory lead
implantable cardioverter‐defibrillator lead
lead failure
Linox
mortality
title Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
title_full Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
title_fullStr Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
title_full_unstemmed Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
title_short Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
title_sort impact of fracture prone implantable cardioverter defibrillator leads on long term patient mortality
topic advisory lead
implantable cardioverter‐defibrillator lead
lead failure
Linox
mortality
url https://doi.org/10.1002/joa3.12843
work_keys_str_mv AT toshiharukoike impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT morioshoda impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT koichiroejima impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT daigoyagishita impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT atsushisuzuki impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT shunhasegawa impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT shoheikataoka impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT kyoichiroyazaki impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT satoshihiguchi impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT miwakanai impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality
AT junichiyamaguchi impactoffractureproneimplantablecardioverterdefibrillatorleadsonlongtermpatientmortality